Recombinant multi-species FOXG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FOXG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
The Alternative Names of target: 2900064B05Rik,BF-1,BF1,BF1),BF1A,BF2,Bf1,Brain factor 1 (BF-1,Brain factor 2 (BF-2,FHKL3,FKH2,FKHL1,FKHL2,FKHL3,FKHL4,FOXG1,FOXG1A,FOXG1B,FOXG1C,Fkhl1,Forkhead box protein G1,Forkhead box protein G1A,Forkhead box protein G1B,Forkhead box protein G1C,Forkhead-related protein FKHL1 (HFK1),Forkhead-related protein FKHL2 (HFK2),Forkhead-related protein FKHL3 (HFK3),Foxg1,HBF-1,HBF-2,HBF-3,HBF-G2,HBF2,HFK1,HFK2,HFK3,Hfh9,Hfhbf1,KHL2,QIN,RATBF1A,hBF-2)

Target products collectionGo to FOXG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6625-Ag-1/ GM-Tg-hg-IP6625-Ag-2 Human FOXG1 protein Human
GM-Tg-rg-IP6625-Ag-1/ GM-Tg-rg-IP6625-Ag-2 Rat FOXG1 protein Rat
GM-Tg-mg-IP6625-Ag-1/ GM-Tg-mg-IP6625-Ag-2 Mouse FOXG1 protein Mouse
GM-Tg-cynog-IP6625-Ag-1/ GM-Tg-cynog-IP6625-Ag-2 Cynomolgus/Rhesus macaque FOXG1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6625-Ag-1/ GM-Tg-felg-IP6625-Ag-2 Feline FOXG1 protein Feline
GM-Tg-cang-IP6625-Ag-1/ GM-Tg-cang-IP6625-Ag-2 Canine FOXG1 protein Canine
GM-Tg-bovg-IP6625-Ag-1/ GM-Tg-bovg-IP6625-Ag-2 Bovine FOXG1 protein Bovine
GM-Tg-equg-IP6625-Ag-1/ GM-Tg-equg-IP6625-Ag-2 Equine FOXG1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6625-Ag-1/ GM-Tg-hg-IP6625-Ag-2; GM-Tg-rg-IP6625-Ag-1/ GM-Tg-rg-IP6625-Ag-2;
GM-Tg-mg-IP6625-Ag-1/ GM-Tg-mg-IP6625-Ag-2; GM-Tg-cynog-IP6625-Ag-1/ GM-Tg-cynog-IP6625-Ag-2;
GM-Tg-felg-IP6625-Ag-1/ GM-Tg-felg-IP6625-Ag-2; GM-Tg-cang-IP6625-Ag-1/ GM-Tg-cang-IP6625-Ag-2;
GM-Tg-bovg-IP6625-Ag-1/ GM-Tg-bovg-IP6625-Ag-2; GM-Tg-equg-IP6625-Ag-1/ GM-Tg-equg-IP6625-Ag-2
Products Name FOXG1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name FOXG1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FOXG1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.